Der er imidlertid ikke observeret klinisk relevante interaktioner eller ændringer i desloratadin- plasmakoncentrationer i kliniske undersøgelser, hvor desloratadin blev administreret samtidig med erythromycin eller ketoconazol.
However, no clinically relevant interactions or changes in desloratadine plasma concentrations were observed in clinical trials with desloratadine in which erythromycin or ketoconazole were co-administered.